Table 5 IPTp uptake against factors that affect access to health facility and health provider DOT adherence
Characteristic | N (Total = 426) | % of women who took IPTp | |||
|---|---|---|---|---|---|
≤2 doses | 95%CI | 3+ doses | 95% CI | ||
Took SP under DOTa each time | |||||
 Yes | 376 | 252 (67.0) | 62.1–71.6 | 124 (32.9) | 28.4–37.9 |
 No | 50 | 47 (94.0) | 82.8–98.1 | 3 (6.0) | 1.9–17.2 |
Distance to HF | |||||
 Small problem | 348 | 233 (67.0) | 61.8–71.7 | 115 (33.1) | 28.3–38.2 |
 Big problem | 78 | 66 (84.6) | 74.7–91.1 | 12 (15.4) | 8.9–25.3 |
Transport to HF | |||||
 Small problem | 344 | 231 (67.2) | 61.9–71.9 | 113 (32.9) | 28.1–38.0 |
 Big problem | 82 | 68 (82.9) | 73.1–89.7 | 14 (17.1) | 10.3–26.9 |
Worried no health provider at HF | |||||
 Small problem | 280 | 183 (65.4) | 59.6–70.7 | 97 (34.6) | 29.3–40.4 |
 Big problem | 146 | 116 (79.5) | 72.1–85.3 | 30 (20.0) | 14.7–27.9 |
Worried no drugs at HF | |||||
 Small problem | 263 | 172 (65.4) | 59.4–70.9 | 91 (34.6) | 29.1–40.6 |
 Big problem | 163 | 127 (77.9) | 70.8–83.6 | 36 (22.1) | 16.3–29.1 |